Tau phosphorylation in Alzheimer's disease: potential involvement of an APP-MAP kinase complex
- PMID: 15626821
- DOI: 10.1385/NMM:5:3:205
Tau phosphorylation in Alzheimer's disease: potential involvement of an APP-MAP kinase complex
Abstract
The two predominant pathological concomitants of Alzheimer's disease (AD) are senile plaques and neurofibrillary tangles. Although many biochemical studies have addressed the composition and formation of these AD hallmarks, very little is known about the interrelationship between the two. Here we present evidence that the tau phosphorylation characteristic of neurofibrillary tangles may be mediated by a physical association of MKK6 (mitogen-associated protein kinase kinase 6) with tau and subsequent phosphorylation of tau by the MKK6 substrate, p38 MAPK; and that APP (beta-amyloid precursor protein) may be co-immunoprecipitated both with MKK6 and its upstream MAPKKK, ASK1. Taken together with recent data demonstrating APP dimerization by beta-amyloid peptide (Abeta) (Lu et al., 2003), and the possible activation of ASK1 via APP dimerization (Hashimoto et al., 2003), these results suggest a model of AD in which Abeta peptide dimerizes APP directly, leading to the activation of ASK1, MKK6, and p38, with subsequent phosphorylation of tau at sites characteristic of AD.
Similar articles
-
Glucose deprivation increases tau phosphorylation via P38 mitogen-activated protein kinase.Aging Cell. 2015 Dec;14(6):1067-74. doi: 10.1111/acel.12381. Epub 2015 Jul 29. Aging Cell. 2015. PMID: 26219917 Free PMC article.
-
Amyloid precursor protein reduction enhances the formation of neurofibrillary tangles in a mutant tau transgenic mouse model.Neurobiol Aging. 2017 Jul;55:202-212. doi: 10.1016/j.neurobiolaging.2017.03.031. Epub 2017 Apr 5. Neurobiol Aging. 2017. PMID: 28464981
-
Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice.Acta Neuropathol. 2014 May;127(5):685-98. doi: 10.1007/s00401-014-1259-1. Epub 2014 Feb 15. Acta Neuropathol. 2014. PMID: 24531886
-
Roles of O-GlcNAcylation on amyloid-β precursor protein processing, tau phosphorylation, and hippocampal synapses dysfunction in Alzheimer's disease.Neurol Res. 2016 Feb;38(2):177-86. doi: 10.1080/01616412.2015.1133485. Epub 2016 Mar 14. Neurol Res. 2016. PMID: 27078700 Review.
-
Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.Neuromolecular Med. 2002;2(2):151-65. doi: 10.1385/NMM:2:2:151. Neuromolecular Med. 2002. PMID: 12428809 Review.
Cited by
-
Genes and pathways underlying regional and cell type changes in Alzheimer's disease.Genome Med. 2013 May 25;5(5):48. doi: 10.1186/gm452. eCollection 2013. Genome Med. 2013. PMID: 23705665 Free PMC article.
-
Apoptosis signal regulating kinase 1 (ASK1): potential as a therapeutic _target for Alzheimer's disease.Int J Mol Sci. 2014 Jan 29;15(2):2119-29. doi: 10.3390/ijms15022119. Int J Mol Sci. 2014. PMID: 24481061 Free PMC article. Review.
-
P38 activation mediates amyloid-beta cytotoxicity.Neurochem Res. 2005 Jun-Jul;30(6-7):791-6. doi: 10.1007/s11064-005-6872-x. Neurochem Res. 2005. PMID: 16187214
-
Microcurrent therapy as the nonpharmacological new protocol against Alzheimer's disease.Front Aging Neurosci. 2024 Jan 18;16:1344072. doi: 10.3389/fnagi.2024.1344072. eCollection 2024. Front Aging Neurosci. 2024. PMID: 38304741 Free PMC article.
-
The role of Beta-adrenergic receptor blockers in Alzheimer's disease: potential genetic and cellular signaling mechanisms.Am J Alzheimers Dis Other Demen. 2013 Aug;28(5):427-39. doi: 10.1177/1533317513488924. Epub 2013 May 20. Am J Alzheimers Dis Other Demen. 2013. PMID: 23689075 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous